Skip to main content

Severe Maternal Morbidity Up in Medicaid-Enrolled Pregnant Women With Opioid Addiction

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2025.

via HealthDay

WEDNESDAY, Jan. 8, 2025 -- The rate of opioid use disorder (OUD) is high in Medicaid-enrolled pregnant women, and they have a high rate of severe maternal morbidity (SMM), according to a study published online Jan. 7 in JAMA Network Open.

Samantha G. Auty, Ph.D., from the Boston University School of Public Health, and colleagues identified 96,309 pregnant women with OUD enrolled in Medicaid in 47 states with 108,975 deliveries in a cross-sectional study to estimate the rates of SMM.

The researchers found that across states, the mean rate of OUD among pregnant women enrolled in Medicaid was 324.8 per 10,000 live births. In this group, the mean unadjusted rate of SMM, excluding blood transfusions, among those with OUD was 292.1 per 10,000 live births, with substantial variation seen across states from 101.0 to 682.2 per 10,000 live births in South Dakota and California, respectively. The estimated rate of SMM was not meaningfully altered with adjustment for enrollee characteristics and comorbidities. With decreased durations of Medicaid enrollment, rates of SMM generally increased.

"State Medicaid programs are uniquely positioned to implement strategies that address the burden of SMM among pregnant people with OUD," the authors write. "Doing so will require early identification of pregnant Medicaid enrollees with OUD and implementation of targeted strategies to increase engagement with perinatal care and SUD treatment."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Specific Antiseizure Medications Associated With Major Malformations in Infants

FRIDAY, July 18, 2025 -- Maternal use of valproate, phenobarbital, and topiramate early in pregnancy is associated with an increased risk for major malformations in infants...

ENDO: Guidelines Developed for Pregnancy Care in Preexisting Diabetes

FRIDAY, July 18, 2025 -- In a joint clinical practice guideline issued by the Endocrine Society and European Society of Endocrinology, recommendations are presented for pregnancy...

Cerebroplacental Ratio Better Guides Delivery With Perceived Less Fetal Movement

THURSDAY, July 17, 2025 -- An additional ultrasound measurement to assess resistance in fetal blood vessels can improve the decision of whether to expedite birth when a woman in...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.